Bausch Health Cos Price to Book Ratio 2010-2024 | BHC

Historical price to book ratio values for Bausch Health Cos (BHC) over the last 10 years. The current price to book ratio for Bausch Health Cos as of December 20, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Bausch Health Cos Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-12-20 7.47 0.00
2024-09-30 8.16 $-0.66 -12.40
2024-06-30 6.97 $-0.62 -11.27
2023-12-31 8.02 $-0.22 -35.72
2023-09-30 8.22 $-0.64 -12.77
2023-06-30 8.00 $0.74 10.75
2023-03-31 8.10 $0.40 20.31
2022-12-31 6.28 $0.72 8.74
2024-03-31 10.61 $-0.47 -22.36
2022-09-30 6.89 $1.20 5.76
2022-06-30 8.36 $0.70 11.95
2022-03-31 22.85 $-0.39 -58.56
2021-12-31 27.61 $-0.09 -291.86
2021-09-30 27.85 $-0.38 -74.11
2021-06-30 29.32 $-1.70 -17.21
2021-03-31 31.74 $-0.35 -91.65
2020-12-31 20.80 $1.70 12.22
2020-09-30 15.54 $1.84 8.42
2020-06-30 18.29 $1.54 11.89
2020-03-31 15.50 $2.23 6.96
2019-12-31 29.92 $3.22 9.29
2019-09-30 21.85 $7.26 3.01
2019-06-30 25.22 $7.63 3.30
2019-03-31 24.70 $7.90 3.13
2018-12-31 18.47 $8.05 2.30
2018-09-30 25.67 $9.26 2.77
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.672B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $24.142B 7.92
Dr Reddy's Laboratories (RDY) India $12.621B 24.15
BridgeBio Pharma (BBIO) United States $4.953B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.975B 26.90
Amphastar Pharmaceuticals (AMPH) United States $1.894B 11.38
Taysha Gene Therapies (TSHA) United States $0.379B 26.43
Personalis (PSNL) United States $0.372B 0.00
Assembly Biosciences (ASMB) United States $0.100B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.008B 0.00
Teligent (TLGT) United States $0.000B 0.00